Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
4.13M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
694K
-
Shares change
-
+105K
-
Total reported value, excl. options
-
$1.51M
-
Value change
-
+$240K
-
Number of buys
-
12
-
Number of sells
-
-4
-
Price
-
$2.17
Significant Holders of IN8BIO, INC. - Common Stock, $0.0001 Par Value Per Share (INAB) as of Q3 2025
19 filings reported holding INAB - IN8BIO, INC. - Common Stock, $0.0001 Par Value Per Share as of Q3 2025.
IN8BIO, INC. - Common Stock, $0.0001 Par Value Per Share (INAB) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 694K shares
of 4.13M outstanding shares and own 16.79% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (190K shares), Stonepine Capital Management, LLC (159K shares), Alyeska Investment Group, L.P. (82.5K shares), VANGUARD GROUP INC (59.4K shares), TWO SIGMA INVESTMENTS, LP (49.5K shares), TWO SIGMA ADVISERS, LP (45.8K shares), JANE STREET GROUP, LLC (26.2K shares), CITADEL ADVISORS LLC (24.7K shares), GEODE CAPITAL MANAGEMENT, LLC (19.3K shares), and DRW Securities, LLC (18.3K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.